CEACAM6 promotes gastric cancer invasion and metastasis by inducing Epithelial-Mesenchymal transition via PI3K/AKT signaling pathway

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Zang, Mingde ^a   Zhang, Baogui ^a   Zhang, Yunqiang ^a   Li, Jianfang ^a   Su, Liping ^a   Zhu, Zhenggang ^a   Gu, Qinlong ^a   Liu, Bingya ^a   Yan, Min ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; GELATINASE B; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR SLUG; UVOMORULIN; VIMENTIN; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CADHERIN; CEACAM6 PROTEIN, HUMAN; CELL ADHESION MOLECULE; CHROMONE DERIVATIVE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LEUKOCYTE ANTIGEN; MORPHOLINE DERIVATIVE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER MORPHOLOGY; CANCER PROGNOSIS; CANCER STAGING; CEACAM6 GENE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GASTRIC CANCER CELL LINE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE LOCATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC CORRELATION; GENETIC MARKER; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PERITONEUM METASTASIS; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STOMACH CANCER; TISSUE DISTRIBUTION; TUMOR GENE; TUMOR INVASION; UPREGULATION; VERY ELDERLY; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CELL MOTION; CYTOSKELETON; DRUG EFFECTS; GENETICS; METABOLISM; MIDDLE AGED; MOUSE; NUDE MOUSE; PATHOLOGY; PERITONEUM TUMOR; PHOSPHORYLATION; SECONDARY; STOMACH TUMOR; TUMOR CELL LINE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, CD; CADHERINS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MOVEMENT; CHROMONES; CYTOSKELETON; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GPI-LINKED PROTEINS; HUMANS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; MORPHOLINES; NEOPLASM INVASIVENESS; PERITONEAL NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; VIMENTIN;

EID: 84911897674     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112908     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin, 61: 69-90.
2. Correa P (2013) Gastric cancer: overview. Gastroenterol Clin North Am, 42: 211-217.
3. Fujitani K (2013) Overview of adjuvant and neoadjuvant therapy for resectable gastric cancer in the East. Dig Surg, 30: 119-129.
4. Scholzel S, Zimmermann W, Schwarzkopf G, Grunert F, Rogaczewski B, et al. (2000) Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas. Am J Pathol, 156: 595-605.
5. Jantscheff P, Terracciano L, Lowy A, Glatz-Krieger K, Grunert F, et al. (2003) Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J Clin Oncol, 21: 3638-3646.
6. Ilantzis C, DeMarte L, Screaton RA, Stanners CP (2002) Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. Neoplasia, 4: 151-163.
7. Duxbury MS, Ito H, Benoit E, Ashley SW, Whang EE (2004) CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness. Br J Cancer, 91: 1384-1390.
8. Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE (2004) CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells. Oncogene, 23: 465-473.
9. Sharma P, Varma R, Sarasij RC, Ira, Gousset K, et al. (2004) Nanoscale organization of multiple GPI-Anchored proteins in living cell membranes. Cell, 116: 577-589.
10. Camacho-Leal P, Zhai AB, Stanners CP (2007) A co-clustering model involving alpha5beta1 integrin for the biological effects of GPI-Anchored human carcinoembryonic antigen (CEA). J Cell Physiol, 211: 791-802.
11. Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, et al. (2004) A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells. Cancer Res, 64: 3987-3993.
12. Zhang Y, Zang M, Li J, Ji J, Zhang J, et al. (2014) CEACAM6 promotes tumor migration, invasion, and metastasis in gastric cancer. Acta Biochim Biophys Sin (Shanghai), 46: 283-290.
13. Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest, 119: 1420-1428.
14. Savagner P (2010) The epithelial-mesenchymal transition (EMT) phenomenon. Ann Oncol, 21 Suppl 7: vii89-92.
15. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell, 139: 871-890.
16. Ruan K, Bao S, Ouyang G (2009) The multifaceted role of periostin in tumorigenesis. Cell Mol Life Sci, 66: 2219-2230.
17. Liang F, Liang J, Wang WQ, Sun JP, Udho E, et al. (2007) PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation. J Biol Chem, 282: 5413-5419.
18. Huber MA, Kraut N, Beug H (2005) Molecular requirements for epithelialmesenchymal transition during tumor progression. Curr Opin Cell Biol, 17: 548-558.
19. Chen J, Li Q, An Y, Lv N, Xue X, et al. (2013) CEACAM6 induces epithelialmesenchymal transition and mediates invasion and metastasis in pancreatic cancer. Int J Oncol, 43: 877-885.
20. Kim KS, Kim JT, Lee SJ, Kang MA, Choe IS, et al. (2013) Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer. Clin Chim Acta, 415: 12-19.
21. Duxbury MS, Matros E, Ito H, Zinner MJ, Ashley SW, et al. (2004) Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer. Ann Surg, 240: 667-674; discussion 675-666.
22. Han SU, Kwak TH, Her KH, Cho YH, Choi C, et al. (2008) CEACAM5 and CEACAM6 are major target genes for Smad3-mediated TGF-beta signaling. Oncogene, 27: 675-683.
23. Kuespert K, Pils S, Hauck CR (2006) CEACAMs: their role in physiology and pathophysiology. Current Opinion in Cell Biology, 18: 565-571.
24. Beauchemin N, Arabzadeh A (2013) Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis. Cancer Metastasis Rev, 32: 643-671.
25. Hu L, Duan YT, Li JF, Su LP, Yan M, et al. (2014) Biglycan enhances gastric cancer invasion by activating FAK signaling pathway. Oncotarget, 5: 1885- 1896.
26. Wang H, Wu Q, Liu Z, Luo X, Fan Y, et al. (2014) Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death Dis, 5: e1155.
27. Macha MA, Rachagani S, Gupta S, Pai P, Ponnusamy MP, et al. (2013) Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling. Cancer Lett, 341: 166-177.
28. Chang L, Graham PH, Hao J, Ni J, Bucci J, et al. (2013) Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance. Cell Death Dis, 4: e875.
29. Ha GH, Park JS, Breuer EK (2013) TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways. Cancer Lett, 332: 63-73.
30. Nicholson TB, Stanners CP (2006) Specific inhibition of GPI-Anchored protein function by homing and self-Association of specific GPI anchors. J Cell Biol, 175: 647-659.